These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11269787)

  • 1. Ergotamine-induced acute vascular insufficiency of the lower limb--a case report.
    Halloul Z; Meyer F; Lippert H; Buerger T
    Angiology; 2001 Mar; 52(3):217-21. PubMed ID: 11269787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of ergotism with Iloprost--a case report.
    Piquemal R; Emmerich J; Guilmot JL; Fiessinger JN
    Angiology; 1998 Jun; 49(6):493-7. PubMed ID: 9631897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiospastic occlusion of the superficial femoral artery by chronic ergotamine intake].
    Bogun N; Mathies R; Bäsecke J
    Dtsch Med Wochenschr; 2011 Jan; 136(1-2):23-6. PubMed ID: 21181611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ergotamine-induced lower extremity arterial vasospasm presenting as acute limb ischemia.
    Demir S; Akin S; Tercan F; Ariboğan A; Oğuzkurt L
    Diagn Interv Radiol; 2010 Jun; 16(2):165-7. PubMed ID: 19821256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of ergotamine-induced vasospasm following methylprednisolone.
    Rahman A; Yildiz M; Dadas E; Donder E; Cihangiroglu M; Eken C; Bozdemir MN
    Clin Toxicol (Phila); 2008 Dec; 46(10):1074-6. PubMed ID: 18763151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral arterial insufficiency during ergotamine treatment. Course of disease, angiographical findings, and treatment by phenoxybenzamine.
    Hessov I; Kromann-Andersen C; Madsen B
    Dan Med Bull; 1972 Oct; 19(7):236-44. PubMed ID: 5079929
    [No Abstract]   [Full Text] [Related]  

  • 7. Mesenteric and peripheral vascular ischemia secondary to ergotism.
    Greene FL; Ariyan S; Stansel HC
    Surgery; 1977 Feb; 81(2):176-9. PubMed ID: 835086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition and treatment of arterial insufficiency from cafergot.
    Wells KE; Steed DL; Zajko AB; Webster MW
    J Vasc Surg; 1986 Jul; 4(1):8-15. PubMed ID: 3723691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spasms of the main muscular arteries in the extremities following ingestion of ergotamine-containing drugs].
    Bollinger A; Preter B
    Dtsch Med Wochenschr; 1973 Apr; 98(16):825-9. PubMed ID: 4695411
    [No Abstract]   [Full Text] [Related]  

  • 10. [Limb ischemia and mitral valve defect as complication of migraine medication].
    Pohjola-Sintonen S
    Duodecim; 1992; 108(6):558-61. PubMed ID: 1366115
    [No Abstract]   [Full Text] [Related]  

  • 11. A case report of multiple fractures with arterial vasospasm associated with ergotamine use.
    Küçükalp A; Durak K; Bilgen MS
    Ulus Travma Acil Cerrahi Derg; 2013 Sep; 19(5):475-9. PubMed ID: 24214792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute ischemia of the lower limbs due to ergotamine-induced arteriospasm].
    Faivre G; Neimann JL; Stehlin H; Christophe P
    Cah Med; 1973 Nov; 14(13):1083-6. PubMed ID: 4792079
    [No Abstract]   [Full Text] [Related]  

  • 13. [Critical ischaemia of the limbs and localized livedo in a case of ergotism].
    Stammler F; Ysermann M
    Dtsch Med Wochenschr; 2002 Jan; 127(4):144-8. PubMed ID: 11807658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The application of digital subtraction angiography in patients with peripheral arterial insufficiency and suspicion of stenosis/occlusion of the superficial femoral artery: intravenous or intra-arterial?].
    Andresen J; Baekgaard N; Pedersen PR
    Aktuelle Radiol; 1991 Sep; 1(5):253-5. PubMed ID: 1751561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular insufficiency secondary to ergotism.
    Kempczinski RF; Buckley CJ; Darling RC
    Surgery; 1976 May; 79(5):597-600. PubMed ID: 1265671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perianal ergotismus gangraenosus].
    Brandt O; Abeck D; Breitbart E; Ring J
    Hautarzt; 1997 Mar; 48(3):199-202. PubMed ID: 9182093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular fibrillation secondary to ergotamine in a healthy young woman.
    Velez Roa S; Preumont N; Mols P; Stoupel E; Renard M
    Acta Cardiol; 1999 Oct; 54(5):283-6. PubMed ID: 10596308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ergot induced peripheral vascular insufficiency, non-interventional treatment.
    McKiernan TL; Bock K; Leya F; Grassman E; Lewis B; Johnson SA; Scanlon PJ
    Cathet Cardiovasc Diagn; 1994 Mar; 31(3):211-4. PubMed ID: 7912993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ergot-induced vasospasm of the lower extremities treated with epidural anaesthesia.
    Semb BK; Molster A; Halvorsen JF; Tvete S
    Scand J Thorac Cardiovasc Surg; 1975; 9(3):254-8. PubMed ID: 1209209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of threatening limb loss ischemia of the upper limb caused by ergotamine. A case report and review of the literature.
    Safar HA; Alanezi KH; Cinà CS
    J Cardiovasc Surg (Torino); 2002 Apr; 43(2):245-9. PubMed ID: 11887064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.